Non-invasive test predicts death risk from heart disease

A noninvasive scan that determines the extent of plaque buildup in the heart predicts the likelihood of heart attack or death over a 15-year period, according to a Weill Cornell Medical College research team.

Stress-fighting proteins could lead to asthma treatments

Weill Cornell Medical College investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body.

Food order impacts glucose and insulin levels

Weill Cornell Medical College researchers have found that the order in which obese patients with type 2 diabetes eat food matters and may help control glucose levels.

Potential new HIV therapy seen in immune cells

Weill Cornell Medical College scientists have discovered a way to limit replication of the most common form of HIV at a key moment when the infection is just starting to develop.

$50M gift creates Meinig School of Biomedical Engineering

A decade after its creation, the Department of Biomedical Engineering has received a $50 million gift that will expand and elevate it as the Nancy E. and Peter C. Meinig School of Biomedical Engineering.

Engineers' synthetic immune organ produces antibodies

Cornell engineers have created a synthetic immune organ that produces antibodies and can be controlled in the lab, completely separate from a living organism.

Stem cell technology could lead to ailing heart mending itself

A new technique, published May 28 in Stem Cell Reports, could allow scientists to generate large numbers of rare cells in the network that pushes the heart's chambers to consistently contract.

Weill Cornell Graduate School honors Avery August

Avery August, professor in the College of Veterinary Medicine, was awarded the Weill Cornell Graduate School of Medical Sciences Distinguished Alumnus Award May 27.

Clinical test validates precision medicine for cancer

A Weill Cornell Medical College research team has shown how next-generation genome sequencing can offer new insights and treatment targets in patients with advanced, treatment-resistant cancer.